Extract from the Register of European Patents

EP About this file: EP1142893

EP1142893 - Substituted 6(4)-benzyloxypyrimidines [Right-click to bookmark this link]
Former [2001/41]Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines
[2004/31]
StatusNo opposition filed within time limit
Status updated on  04.11.2005
Database last updated on 11.04.2026
Most recent event   Tooltip04.11.2005No opposition filed within time limitpublished on 21.12.2005  [2005/51]
Applicant(s)For all designated states
THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services
National Institutes of Health, Office of Technology Transfer, Box OTT
Bethesda, MD 20892-9902 / US
For all designated states
Arch Development Corporation
1101 East 58th Street, The University of Chicago Chicago
Illinois 60637 / US
For all designated states
THE PENN STATE RESEARCH FOUNDATION, INC.
113 Technology Center
University Park, PA 16802 / US
[N/P]
Former [2001/41]For all designated states
THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services
National Institutes of Health, Office of Technology Transfer, Box OTT
Bethesda, MD 20892-9902 / US
For all designated states
ARCH DEVELOPMENT CORPORATION
1101 East 58th Street, The University of Chicago
Chicago, Illinois 60637 / US
For all designated states
THE PENN STATE RESEARCH FOUNDATION, INC.
113 Technology Center
University Park, PA 16802 / US
Inventor(s)01 / Moschel, Robert, C.
B204 Glendale Drive
Frederick MD 21702 / US
02 / Pegg, Anthony, E.
9 Brownstone Drive
Hershey PA 17033 / US
03 / Dolan, Eilleen, M.
B21 S.East Avenue
Oak Park Illinois 60304 / US
04 / Chae, Mi-Young
Mocklyoun Apt. 308-205, Hogyoue-Dong, Dongan-Gu
Anyang-Shi, Kyoungki-Do, 431-080 / KR
 [2001/43]
Former [2001/41]01 / Moschel, Robert, C.
B204 Glendale Drive
Frederick MD 21702 / US
02 / Pegg, Anthony, E.
9 Brownstone Drive
Hershey PA 17033 / US
03 / Dolan, Eilleen, M.
B21 S.East Avenue
Oak Park Illinois 60304 / US
04 / Chae, Mi-Young
Apartment 203, 1418H Taney Avenue
Frederick MD 21702 / US
Representative(s)Nicholls, Kathryn Margaret, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2001/41]Nicholls, Kathryn Margaret, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date01108585.931.07.1995
[2001/41]
Priority number, dateUS1994028395301.08.1994         Original published format: US 283953
[2001/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1142893
Date:10.10.2001
Language:EN
[2001/41]
Type: B1 Patent specification 
No.:EP1142893
Date:29.12.2004
Language:EN
[2004/53]
Search report(s)(Supplementary) European search report - dispatched on:EP27.07.2001
ClassificationIPC:C07D473/18, C07D487/04, C07D473/06, C07D473/40, C07D239/46, C07D239/48, C07D239/50, C07D251/52, A61K31/52, A61K31/505, A61K31/519, A61P35/00, // (C07D487/04, 249:00, 239:00)
[2001/41]
CPC:
C07D239/47 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07D239/48 (EP,US); C07D239/50 (EP,US); C07D251/52 (EP,US);
C07D473/06 (EP,US); C07D473/18 (EP,US); C07D473/40 (EP,US);
C07D487/04 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/41]
TitleGerman:Substituierte 6(4)-Benzyloxypyrimidine[2004/31]
English:Substituted 6(4)-benzyloxypyrimidines[2004/31]
French:6(4)-benzyloxypyrimidines substituées[2004/31]
Former [2001/41]Substituierte O6-Benzylguanine und 6(4)-Benzyloxypyrimidine
Former [2001/41]Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines
Former [2001/41]O6-benzylguanines et 6(4)-benzyloxypyrimidines substituées
Examination procedure23.04.2001Examination requested  [2001/41]
28.05.2003Despatch of a communication from the examining division (Time limit: M06)
08.12.2003Reply to a communication from the examining division
20.01.2004Despatch of a communication from the examining division (Time limit: M04)
28.05.2004Reply to a communication from the examining division
24.06.2004Communication of intention to grant the patent
01.11.2004Fee for grant paid
01.11.2004Fee for publishing/printing paid
Parent application(s)   TooltipEP95928237.7  / EP0775142
Divisional application(s)EP04030121.0  / EP1518854
Opposition(s)30.09.2005No opposition filed within time limit [2005/51]
Fees paidRenewal fee
23.04.2001Renewal fee patent year 03
23.04.2001Renewal fee patent year 04
23.04.2001Renewal fee patent year 05
23.04.2001Renewal fee patent year 06
23.04.2001Renewal fee patent year 07
22.07.2002Renewal fee patent year 08
23.07.2003Renewal fee patent year 09
22.07.2004Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]   CHEMICAL ABSTRACTS, vol. 101, no. 25, 17 December 1984, Columbus, Ohio, US; abstract no. 230466q, page 765; column R; XP002169245 [A] 10 * abstract *
 [A]   RAM SIYA ET AL, HETEROCYCLES, vol. 22, no. 8, 1984, pages 1789 - 1790
 [A]   MORRIS J. ROBINS ET AL, THE JOURNAL OF ORGANIC CHEMISTRY, vol. 34, no. 7, July 1969 (1969-07-01), pages 2160 - 2163, XP002169241 [A] 10 * the whole document *

DOI:   http://dx.doi.org/10.1021/jo01259a029
 [DA]   MI-YOUNG CHAE ET AL, JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 3, 4 February 1994 (1994-02-04), pages 342 - 347, XP002169242 [DA] 1-25 *Article*

DOI:   http://dx.doi.org/10.1021/jm00029a005
 [DA]   ROBERT C. MOSCHEL ET AL, JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 23, 13 November 1992 (1992-11-13), pages 4486 - 4491, XP002169243 [DA] 1-25 *Article*

DOI:   http://dx.doi.org/10.1021/jm00101a028
 [PX]   MI-YOUNG CHAE ET AL, JOURNAL OF MEDICINAL CHEMISTRY, vol. 38, no. 2, 20 January 1995 (1995-01-20), pages 359 - 365, XP002169244 [PX] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00002a018
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.